Insulet (NASDAQ:PODD – Get Free Report) and United Health Products (OTCMKTS:UEEC – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, profitability, institutional ownership, earnings and valuation.
Risk & Volatility
Insulet has a beta of 1.42, indicating that its share price is 42% more volatile than the S&P 500. Comparatively, United Health Products has a beta of -0.89, indicating that its share price is 189% less volatile than the S&P 500.
Insider and Institutional Ownership
0.1% of United Health Products shares are held by institutional investors. 0.4% of Insulet shares are held by company insiders. Comparatively, 1.5% of United Health Products shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Analyst Recommendations
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Insulet | 1 | 3 | 20 | 0 | 2.79 |
| United Health Products | 0 | 0 | 0 | 0 | 0.00 |
Insulet currently has a consensus price target of $354.57, indicating a potential upside of 45.98%. Given Insulet’s stronger consensus rating and higher possible upside, equities research analysts plainly believe Insulet is more favorable than United Health Products.
Profitability
This table compares Insulet and United Health Products’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Insulet | 9.12% | 24.90% | 10.73% |
| United Health Products | N/A | N/A | -2,141.74% |
Earnings & Valuation
This table compares Insulet and United Health Products”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Insulet | $2.71 billion | 6.31 | $247.10 million | $3.50 | 69.40 |
| United Health Products | N/A | N/A | -$2.00 million | ($0.02) | -3.00 |
Insulet has higher revenue and earnings than United Health Products. United Health Products is trading at a lower price-to-earnings ratio than Insulet, indicating that it is currently the more affordable of the two stocks.
Summary
Insulet beats United Health Products on 11 of the 13 factors compared between the two stocks.
About Insulet
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
About United Health Products
United Health Products, Inc. develops, manufactures, and markets hemostatic gauze products for the healthcare and wound care sectors in the United States. The company offers HemoStyp hemostatic gauze products to absorb exudate/drainage from superficial wounds, as well as helps in controlling bleeding. It serves hospitals and surgery centers, clinics and physicians, military medical care providers, hemodialysis centers, nursing homes and assisted living, and veterinary hospitals; and EMS, fire departments, and other first responders, as well as dental, oral, and maxillofacial surgery offices. The company was formerly known as United EcoEnergy Corp. and changed its name to United Health Products, Inc. in September 2010. United Health Products, Inc. was incorporated in 1997 and is headquartered in Mount Laurel, New Jersey.
Receive News & Ratings for Insulet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Insulet and related companies with MarketBeat.com's FREE daily email newsletter.
